Real World Evidence is becoming more important in assessing the benefit of new medical interventions. Helping us understand the impact on Patient Reported Outcomes in a real-world setting will be critical to support future reimbursement and regulatory approvals. DaSH Global supports the drug approval process through the power of delivering cost-efficient, timely and precise evidence from unique real-world research methodologies. Specialising in MedTech strategies & products through our vision of building collaborative ‘disruptive’ transformational Patient Reported Outcomes (PRO) research platforms from ‘joined up’ health care. DaSH have developed the Digital Assessment Xchange (DAX) as an integrated healthcare research platform for the outcomes assessment of patients with cancers. DAX is being set up to collect longitudinal 'community based' PROMs, Patient Experience & Indirect Costs outside the routine doctor consultation.